Galderma Group N

Swiss Stock Exchange GALD.SW

Galderma Group N EBITDA for the year ending December 31, 2023: USD 820.07 M

Galderma Group N EBITDA is USD 820.07 M for the year ending December 31, 2023, a 28.05% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Galderma Group N EBITDA for the year ending December 31, 2022 was USD 640.44 M, a 22.74% change year over year.
  • Galderma Group N EBITDA for the year ending December 31, 2021 was USD 521.81 M.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Swiss Stock Exchange: GALD.SW

Galderma Group N

CEO Dr. Flemming Ornskov M.B.A., M.P.H.
IPO Date March 21, 2024
Location Switzerland
Headquarters Zählerweg 10
Employees 6,545
Sector Consumer Discretionary
Industries
Cosmetics
Description

Galderma Group AG is engaged in cosmetic industry. Its segment includes Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.

StockViz Staff

January 15, 2025

Any question? Send us an email